mhurhangee/ep-ind-claims huggingface dataset:
A catheter assembly for capturing emboli dislodged from an arterial lesion, the assembly comprising: a catheter body including a lumen, the catheter body sized for endoluminal advancement of a distal end portion of the catheter assembly from a puncture site at a human artery selected from a dorsalis pedis artery, a fibular artery, an anterior tibial artery, and a posterior tibial artery toward one or more larger arteries and toward a distal end of the arterial lesion; an insertion profile and a deployment profile; and an embolic protection device configured with: a collapsed state when stowed in the lumen at the distal end portion of the catheter assembly in the insertion profile; and a deployed state when outside the lumen in the deployment profile, the deployed state configured with a retrograde opening away from the catheter body and toward a distal end or distal cap of an arterial lesion for capturing emboli dislodged from the arterial lesion; and wherein the catheter body further includes one or more additional lumens, each lumen of the one or more additional lumens independently configured for flushing an arterial lumen around a distal end of an arterial lesion, aspirating emboli dislodged from an arterial lesion, or both flushing and aspirating in accordance with the foregoing. a catheter body including a lumen, the catheter body sized for endoluminal advancement of a distal end portion of the catheter assembly from a puncture site at a human artery selected from a dorsalis pedis artery, a fibular artery, an anterior tibial artery, and a posterior tibial artery toward one or more larger arteries and toward a distal end of the arterial lesion; an insertion profile and a deployment profile; and an embolic protection device configured with: a collapsed state when stowed in the lumen at the distal end portion of the catheter assembly in the insertion profile; and a deployed state when outside the lumen in the deployment profile, the deployed state configured with a retrograde opening away from the catheter body and toward a distal end or distal cap of an arterial lesion for capturing emboli dislodged from the arterial lesion; and a collapsed state when stowed in the lumen at the distal end portion of the catheter assembly in the insertion profile; and a deployed state when outside the lumen in the deployment profile, the deployed state configured with a retrograde opening away from the catheter body and toward a distal end or distal cap of an arterial lesion for capturing emboli dislodged from the arterial lesion; and wherein the catheter body further includes one or more additional lumens, each lumen of the one or more additional lumens independently configured for flushing an arterial lumen around a distal end of an arterial lesion, aspirating emboli dislodged from an arterial lesion, or both flushing and aspirating in accordance with the foregoing.
A method for reporting a flight mode, applicable to an unmanned aerial vehicle, UAV, in a first mode, comprising: when the UAV is in a connected state, changing the flight mode from the first mode to a second mode, wherein the UAV in the connected state is capable of reporting a changed flight mode to a base station, wherein when the first mode is a fixed mode, the second mode is a dynamic mode, or when the first mode is a dynamic mode, the second mode is a fixed mode, wherein in the fixed mode, a flight route of the UAV is planed through a controller, and in the dynamic mode, the UAV is controlled remotely through the controller; sending a flight mode change notification of the UAV to the base station to notify the base station that the flight mode of the UAV is changed from the first mode to the second mode. when the UAV is in a connected state, changing the flight mode from the first mode to a second mode, wherein the UAV in the connected state is capable of reporting a changed flight mode to a base station, wherein when the first mode is a fixed mode, the second mode is a dynamic mode, or when the first mode is a dynamic mode, the second mode is a fixed mode, wherein in the fixed mode, a flight route of the UAV is planed through a controller, and in the dynamic mode, the UAV is controlled remotely through the controller; sending a flight mode change notification of the UAV to the base station to notify the base station that the flight mode of the UAV is changed from the first mode to the second mode.
A fluid flow pump comprising a suction inlet, a discharge outlet, a chamber in fluid flow connection with the suction inlet and with the discharge outlet, a movable part arranged inside the chamber, and at least one motor mechanically connected to the movable part to move it inside the chamber, wherein the pump includes a first upstream lip placed closer to the suction inlet than to the discharge outlet and a first downstream lip placed closer to the discharge outlet than to the suction inlet, these first upstream and downstream lips (120a, 121a) being placed between one of the sides of said movable part and a first wall of the chamber to define a first space between the first upstream and downstream lips (120a, 121a), these first upstream and downstream lips (120a, 121a) being such that: · over a first portion of said movement of said movable part relative to the chamber, the first downstream lip provides sealing preventing fluid from passing from said discharge outlet to said first space, the first upstream lip being always spaced apart from the first wall for allowing free passage for fluid between said first space and said suction inlet; and that · over a second portion of said reciprocating motion of said movable part relative to the chamber, different from the first portion of the movement, the first upstream lip provides sealing preventing fluid from passing from said first space to said suction inlet, the first downstream lip being arranged so that throughout said movement of said movable part relative to the chamber: · it allows fluid to pass from the first space to said discharge outlet; and · it prevents fluid from passing from said discharge outlet to said first space. · over a first portion of said movement of said movable part relative to the chamber, the first downstream lip provides sealing preventing fluid from passing from said discharge outlet to said first space, the first upstream lip being always spaced apart from the first wall for allowing free passage for fluid between said first space and said suction inlet; and that · over a second portion of said reciprocating motion of said movable part relative to the chamber, different from the first portion of the movement, the first upstream lip provides sealing preventing fluid from passing from said first space to said suction inlet, the first downstream lip being arranged so that throughout said movement of said movable part relative to the chamber: · it allows fluid to pass from the first space to said discharge outlet; and · it prevents fluid from passing from said discharge outlet to said first space. · it allows fluid to pass from the first space to said discharge outlet; and · it prevents fluid from passing from said discharge outlet to said first space.
A method comprising: Receiving, at a mobile terminal (300; 350), position information indicative of a location of the mobile terminal (300; 350) relative to a geographic border, and an indication of an emergency call being placed from the mobile terminal (300;350); and causing modification, at the mobile terminal (300; 350), of a candidate list of cells, or public land mobile networks for cell selection, or public land mobile network selection, based on the position information and a position of the cells relative to the geographic border, wherein said modification comprises one of: eliminating, from the candidate list, cells associated with a public land mobile network that is on an opposite side of the geographic border as the mobile terminal (300; 350); and prioritizing the candidate list to lower a prioritization of cells associated with the public land mobile network that is on the opposite side of the geographic border as the mobile terminal (300; 350), relative to cells associated with a public land mobile network that is on a same side of the geographic border as the mobile terminal (300; 350). Receiving, at a mobile terminal (300; 350), position information indicative of a location of the mobile terminal (300; 350) relative to a geographic border, and an indication of an emergency call being placed from the mobile terminal (300;350); and causing modification, at the mobile terminal (300; 350), of a candidate list of cells, or public land mobile networks for cell selection, or public land mobile network selection, based on the position information and a position of the cells relative to the geographic border, wherein said modification comprises one of: eliminating, from the candidate list, cells associated with a public land mobile network that is on an opposite side of the geographic border as the mobile terminal (300; 350); and prioritizing the candidate list to lower a prioritization of cells associated with the public land mobile network that is on the opposite side of the geographic border as the mobile terminal (300; 350), relative to cells associated with a public land mobile network that is on a same side of the geographic border as the mobile terminal (300; 350).
Method for predicting an outcome of breast cancer in an estrogen receptor positive and HER2 negative tumor of a breast cancer patient, said method comprising: (a) determining in a tumor sample from said patient the RNA expression levels of the following 8 genes: UBE2C, RACGAP1, DHCR7, STC2, AZGP1, RBBP8, IL6ST, and MGP (b) mathematically combining expression level values for the genes of the said set which values were determined in the tumor sample to yield a combined score, wherein said combined score is indicative of a prognosis of said patient. (a) determining in a tumor sample from said patient the RNA expression levels of the following 8 genes: UBE2C, RACGAP1, DHCR7, STC2, AZGP1, RBBP8, IL6ST, and MGP (b) mathematically combining expression level values for the genes of the said set which values were determined in the tumor sample to yield a combined score, wherein said combined score is indicative of a prognosis of said patient.
Inhalatory dry solid pharmaceutical composition comprising a drug, a soluble excipient having a solubility in water greater than 5 g/l, and a surfactant, characterized by: - said soluble excipient comprises leucine which is present in an amount between 10% and less than 100% by weight; - the weight ratio between said surfactant and said drug is between 0.01 and 10; - the particle size of at least 50% of the particles (X 50) of said powder is below 5 μm; - the bulk density d b of said powder is between 0.1 and 0.3 g/cm 3; - the tapped density d t of said powder is between 0.15 and 0.7 g/ cm 3 - the ratio d b /d t is between 0.2 and 0.65; wherein said excipient and said surfactant do not include phospholipids. - said soluble excipient comprises leucine which is present in an amount between 10% and less than 100% by weight; - the weight ratio between said surfactant and said drug is between 0.01 and 10; - the particle size of at least 50% of the particles (X 50) of said powder is below 5 μm; - the bulk density d b of said powder is between 0.1 and 0.3 g/cm 3; - the tapped density d t of said powder is between 0.15 and 0.7 g/ cm 3 - the ratio d b /d t is between 0.2 and 0.65;
A method in a base station for managing multiple user access to a communication link, the method characterized by: receiving from a mobile terminal a user transmission on a contention-based channel of the communication link, the user transmission including a data transmission and a reference signal, the reference signal being derived from a base sequence that is shifted according to a cyclic shift selected by the mobile terminal; determining the cyclic shift selected by the mobile terminal, by detecting the reference signal included in the user transmission; determining which of a plurality of retransmission identifiers is mapped to that cyclic shift according to a defined mapping between cyclic shifts and retransmission identifiers; and upon failing to demodulate the data transmission included in the user transmission: scheduling a retransmission of the user transmission on a schedule-based channel of the communication link; and sending scheduling information for the scheduled retransmission to the mobile terminal, by addressing the scheduling information to the determined retransmission identifier. receiving from a mobile terminal a user transmission on a contention-based channel of the communication link, the user transmission including a data transmission and a reference signal, the reference signal being derived from a base sequence that is shifted according to a cyclic shift selected by the mobile terminal; determining the cyclic shift selected by the mobile terminal, by detecting the reference signal included in the user transmission; determining which of a plurality of retransmission identifiers is mapped to that cyclic shift according to a defined mapping between cyclic shifts and retransmission identifiers; and upon failing to demodulate the data transmission included in the user transmission: scheduling a retransmission of the user transmission on a schedule-based channel of the communication link; and sending scheduling information for the scheduled retransmission to the mobile terminal, by addressing the scheduling information to the determined retransmission identifier. scheduling a retransmission of the user transmission on a schedule-based channel of the communication link; and sending scheduling information for the scheduled retransmission to the mobile terminal, by addressing the scheduling information to the determined retransmission identifier.
A method for the prognosis of the progression of a polycythemia vera to a post-polycythemia vera myelofibrosis (post-PV MF) in a subject, said method comprising the step of analyzing a biological sample from said subject suffering from a PV by determining the presence or the absence of a mutation in the ASXL1 (additional sex combs like 1) gene coding for the polypeptide having the sequence SEQ ID N°2, wherein the presence of an ASXL1 mutation is indicative of a risk of a progression of said PV to Post-PV MF.
A cosmetic product, consisting of - a water-in-oil emulsion containing, based on the weight of the emulsion, a) 5 to 35 wt.% of at least one antiperspirant aluminum salt, b) 5 to 14.25 wt.% ethanol, c) 0 to 13 wt.% 1,2-propanediol, - at least one propellant, - an aerosol-dispensing device. - a water-in-oil emulsion containing, based on the weight of the emulsion, a) 5 to 35 wt.% of at least one antiperspirant aluminum salt, b) 5 to 14.25 wt.% ethanol, c) 0 to 13 wt.% 1,2-propanediol, a) 5 to 35 wt.% of at least one antiperspirant aluminum salt, b) 5 to 14.25 wt.% ethanol, c) 0 to 13 wt.% 1,2-propanediol, - at least one propellant, - an aerosol-dispensing device.
A method for mapping, comprising the steps of: (a) receiving sensor data based on location and a path of movement of a mobile device; (b) generating, based on the sensor data, a path estimate vector and a location measurement vector, (i) said path estimate vector including locations of the movement of the mobile device; and (ii) said location measurement vector including one or more of magnetic field or radio frequency beacon based measurements at each of said locations from the sensor data from each of said locations; and (c) generating one or more unique path features, UPFs, the UPFs characterizing said path, characterized in that said UPFs are generated by performing an operation over said path of movement, wherein the operation is based on said path estimate vector and said location measurement vector. (a) receiving sensor data based on location and a path of movement of a mobile device; (b) generating, based on the sensor data, a path estimate vector and a location measurement vector, (i) said path estimate vector including locations of the movement of the mobile device; and (ii) said location measurement vector including one or more of magnetic field or radio frequency beacon based measurements at each of said locations from the sensor data from each of said locations; and (i) said path estimate vector including locations of the movement of the mobile device; and (ii) said location measurement vector including one or more of magnetic field or radio frequency beacon based measurements at each of said locations from the sensor data from each of said locations; and (c) generating one or more unique path features, UPFs, the UPFs characterizing said path, characterized in that said UPFs are generated by performing an operation over said path of movement, wherein the operation is based on said path estimate vector and said location measurement vector.
A device for displaying a cutting simulation for representing a shape of a workpiece in a voxel model to simulate a change in the shape of the workpiece by a cutting operation, the device comprising: a rendered workpiece image update section for managing a rendered workpiece image buffer and a rendered workpiece depth buffer to hold image data and depth distance data of a projected image of the workpiece and updating by ray tracing a portion in the rendered workpiece image buffer and the rendered workpiece depth buffer, the portion being associated with a rendering region corresponding to a change in the shape of the workpiece, wherein the rendered workpiece image update section starts ray tracing at a location on the surface of the workpiece shape at the time of the previous screen display update defined by a depth distance (w) and coordinates (u,v) of a ray-traced pixel, wherein the rendered workpiece image update section 26 first reads the rendered workpiece depth buffer 23 for the depth distance (w) to the ray-traced pixel; a three-dimensional coordinate point q(u, v, w) obtained by combining the pixel coordinates (u, v) and the depth distance (w) is converted into the coordinate system of the workpiece shape data to find the three-dimensional coordinate point P(x, y, z), and a line segment perpendicular to the projection plane associated with the projected image and starting at the point P in the direction of depth is calculated as ray data. a rendered workpiece image update section for managing a rendered workpiece image buffer and a rendered workpiece depth buffer to hold image data and depth distance data of a projected image of the workpiece and updating by ray tracing a portion in the rendered workpiece image buffer and the rendered workpiece depth buffer, the portion being associated with a rendering region corresponding to a change in the shape of the workpiece, wherein the rendered workpiece image update section starts ray tracing at a location on the surface of the workpiece shape at the time of the previous screen display update defined by a depth distance (w) and coordinates (u,v) of a ray-traced pixel, wherein the rendered workpiece image update section 26 first reads the rendered workpiece depth buffer 23 for the depth distance (w) to the ray-traced pixel; a three-dimensional coordinate point q(u, v, w) obtained by combining the pixel coordinates (u, v) and the depth distance (w) is converted into the coordinate system of the workpiece shape data to find the three-dimensional coordinate point P(x, y, z), and a line segment perpendicular to the projection plane associated with the projected image and starting at the point P in the direction of depth is calculated as ray data.
A composition comprising albumin-bound paclitaxel nanoparticle/antibody complexes, for use in treating lymphoma in a mammal, wherein the average diameter of said complexes of said composition is between 0.1 and 0.9 μm, and wherein said antibody is rituximab.
A system for detecting a functional area of a person's brain leading in said person to hemispatial neglect in case of lesion, said system comprising: - at least one electrode adapted to induce a stimulus in a position of the brain of said person, - means for displaying a geometric shape further to said stimulus, - selection means enabling said person to point, according to a predetermined instruction, to a position relative to said geometric shape, characterized in that it further comprises: - means for determining the position of the stimulus, - means for detecting the position pointed to, - means for comparing said pointed to position to a position computed according to said instruction, and - means (118,120) for emitting a signal on the basis of said comparison, - means for storing the result of the comparison in association with a position of the stimulus, for a plurality of different positions, - means for mapping the functional area on the basis of the position of each of the stimuli and the result of the comparison for each position of the stimuli, on the basis of a map of the brain of said person obtained by means for medical imaging. - at least one electrode adapted to induce a stimulus in a position of the brain of said person, - means for displaying a geometric shape further to said stimulus, - selection means enabling said person to point, according to a predetermined instruction, to a position relative to said geometric shape, characterized in that it further comprises: - means for determining the position of the stimulus, - means for detecting the position pointed to, - means for comparing said pointed to position to a position computed according to said instruction, and - means (118,120) for emitting a signal on the basis of said comparison, - means for storing the result of the comparison in association with a position of the stimulus, for a plurality of different positions, - means for mapping the functional area on the basis of the position of each of the stimuli and the result of the comparison for each position of the stimuli, on the basis of a map of the brain of said person obtained by means for medical imaging.